Revenue: The sum of all revenue fields included for a company's operating activities.
ANI Pharmaceuticals, Inc. (ANIP) had Revenue of $614.38M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$614.38M |
$-20.15M |
|
$250.21M |
|
$364.17M |
|
$613.79M |
|
$0.58M |
|
$-22.80M |
|
$-22.21M |
|
$-22.21M |
|
$-18.52M |
|
$-18.52M |
|
$-18.52M |
|
$-18.52M |
|
$0.58M |
|
$81.91M |
|
19.32M |
|
19.32M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$527.68M |
|
$56.86M |
|
$756.01M |
|
$1.28B |
|
$193.68M |
|
$614.92M |
|
$661.49M |
|
$855.17M |
|
$403.68M |
|
$-173.29M |
|
$428.53M |
|
21.12M |
|
| Cash Flow Statement Financials | |
$64.02M |
|
$-404.72M |
|
$264.94M |
|
$221.12M |
|
$144.89M |
|
$-76.23M |
|
$29.34M |
|
-- |
|
$-1.62M |
|
| Fundamental Metrics & Ratios | |
2.72 |
|
-- |
|
-- |
|
0.59 |
|
1.46 |
|
59.27% |
|
0.10% |
|
0.10% |
|
13.33% |
|
-3.62% |
|
-3.28% |
|
$61.30M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
1.83 |
|
2.77 |
|
131.73 |
|
-4.59% |
|
10.69% |
|
-1.44% |
|
-1.78% |
|
$20.29 |
|
$3.17 |
|
$3.31 |
|